A new medication found to reduce the chance of the most common types of breast cancer recurring will be available to many ...

Diagnosis and treatment of breast cancer can differ for patients in rural communities compared with those in urban ...

Datroway (datopotamab deruxtecan) is the first TROP2-directed therapy approved for advanced lung cancer in the U.S.

A potentially life-saving treatment for early-stage breast cancer will become much more affordable for hundreds of ...

Iksuda Therapeutics (Iksuda), the developer of class-leading antibody drug conjugates (ADCs) with clinically validated tumour-selective payload release formats, today announces that the U.S. Food and ...

Notably, prior to the appointments of Kelly and Aromando, Oncolytics presented new GOBLET data at the 2025 ASCO Annual ...

USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- USA News Group News Commentary - The oncology landscape is being pulled ...

Baystreet.ca News Commentary – The current landscape of oncology is a mixed bag of results, with optimism coming from a ...

Piers Ingram, founder and CEO of Singapore-based Hummingbird Bioscience and its U.S. spin-off Callio Therapeutics, is quietly ...

ACROBiosystems has developed a series of specialized proteases for the screening and validation of ADC linkers, focusing on ...

Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast ...

Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, ...